WO2015020567A8 - Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same - Google Patents

Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same Download PDF

Info

Publication number
WO2015020567A8
WO2015020567A8 PCT/RU2014/000575 RU2014000575W WO2015020567A8 WO 2015020567 A8 WO2015020567 A8 WO 2015020567A8 RU 2014000575 W RU2014000575 W RU 2014000575W WO 2015020567 A8 WO2015020567 A8 WO 2015020567A8
Authority
WO
WIPO (PCT)
Prior art keywords
proliferation
cells
product
producing
regeneration
Prior art date
Application number
PCT/RU2014/000575
Other languages
French (fr)
Other versions
WO2015020567A1 (en
Inventor
Vladimir Georgievich Nesterenko
Vadim Igorevich POSPELOV
Original Assignee
Limited Liability Company "Nearmedic Plus"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Limited Liability Company "Nearmedic Plus" filed Critical Limited Liability Company "Nearmedic Plus"
Publication of WO2015020567A1 publication Critical patent/WO2015020567A1/en
Publication of WO2015020567A8 publication Critical patent/WO2015020567A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the field of pharmacy and medicine and is directed to the provision of a biologically active product for enhancing regeneration and proliferation of cells, wherein the product is a 5-10 molecular weight kDa fraction of a Laminaria angustata water-isobutanol extract subjected to ultrafiltration. The invention also relates to a method for producing said product, and a medicament for regeneration and/or proliferation of cells, comprising said product and a pharmaceutically acceptable additive. The medicament can be used in complex therapy in the treatment of immunodeficiency conditions of different origins, including a health condition after cancer chemotherapy.
PCT/RU2014/000575 2013-08-06 2014-07-31 Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same WO2015020567A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2013136893 2013-08-06
RU2013136893/15A RU2540487C1 (en) 2013-08-06 2013-08-06 Product based on alga laminaria angustata for improvement of regeneration and proliferation of cells, method of its obtaining and application

Publications (2)

Publication Number Publication Date
WO2015020567A1 WO2015020567A1 (en) 2015-02-12
WO2015020567A8 true WO2015020567A8 (en) 2015-07-23

Family

ID=51662291

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2014/000575 WO2015020567A1 (en) 2013-08-06 2014-07-31 Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same

Country Status (2)

Country Link
RU (1) RU2540487C1 (en)
WO (1) WO2015020567A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2717672C1 (en) * 2019-04-05 2020-03-25 Гордейчук Владимир Евгеньевич Method of human immune system cells stimulation
US11534469B2 (en) * 2020-08-25 2022-12-27 Vita Motus AG Method for the stimulation of human immune cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2030885C1 (en) 1991-06-25 1995-03-20 Маслюков Юрий Павлович Algae reprocessing method for obtaining product containing calcium alginate
RU2230464C1 (en) 2002-10-09 2004-06-20 Кудрявцев Олег Николаевич Method for processing algae for preparing product "lamifaren"
JP2008044912A (en) * 2006-08-21 2008-02-28 Univ Of Ryukyus Antitumor agent, hyaluronidase inhibitor or therapeutic agent of atopic dermatitis originated from laminaria angustata var. longissima
JP5414995B2 (en) * 2007-03-27 2014-02-12 国立大学法人鳥取大学 Acidic urine-improving food and drink and pharmaceutical composition for oral administration comprising fucoidan as an active ingredient
JP5306537B2 (en) * 2010-02-24 2013-10-02 森永乳業株式会社 Antibacterial adjuvant, antibacterial composition, and food and drink containing kelp extract as an active ingredient

Also Published As

Publication number Publication date
WO2015020567A1 (en) 2015-02-12
RU2540487C1 (en) 2015-02-10

Similar Documents

Publication Publication Date Title
PH12015500988B1 (en) Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2016008013A (en) Antibody drug conjugates (adcs) with kinesin spindel protein (ksp).
BR112014014262A2 (en) nanoparticles; pharmaceutical composition; method of administering one or more therapeutic, prophylactic, and / or diagnostic agents to a patient in need thereof and method of preparing the particles.
WO2017062619A3 (en) Combination therapy for the treatment of cancer
WO2015165413A8 (en) New stable antibody-drug conjugate, preparation method therefor, and use thereof
WO2016207090A3 (en) Targeted conjugates of ksp inhibitors
TN2012000067A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
TN2016000006A1 (en) Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
MX2017002816A (en) Pyrazolopyridine derivatives and their use in therapy.
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
MY175332A (en) Methods of administering beta7 integrin antagonists
WO2015130554A3 (en) Dosage and administration of anti-igf-1r, anti-erbb3 bispecific antibodies, uses thereof and methods of treatment therewith
WO2017062615A3 (en) Combination therapy for the treatment of cancer
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
WO2016040814A3 (en) Disulfide polymers and methods of use
TN2016000121A1 (en) Cyclic thienouracil-carboxamides and use thereof
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
JP2017061488A5 (en)
WO2015020567A8 (en) Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same
WO2013096335A8 (en) ADMINISTRATION OF AN ANTAGONIST OF α5β1 FOR ANTI-ANTIOGENESIS AND CANCER TREATMENT
WO2013038200A3 (en) Neurodevelopmental disorders
WO2014055941A8 (en) Compounds and methods for targeted immune system delivery
CN105708864A (en) Asthenopia treatment drug

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14781322

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14781322

Country of ref document: EP

Kind code of ref document: A1